The biological products sector fluctuated higher. Tebao Biotech and Sansheng Guojian rose more than 10%, and many stocks such as Rongchang Biotech, Novizan, Zhifei Biotech, and Biotech surged. According to the news, the State Drug Administration reviewed and approved the “Pilot Work Plan for Segmented Production of Biological Products” on October 18.

Zhitongcaijing · 10/18 06:33
The biological products sector fluctuated higher. Tebao Biotech and Sansheng Guojian rose more than 10%, and many stocks such as Rongchang Biotech, Novizan, Zhifei Biotech, and Biotech surged. According to the news, the State Drug Administration reviewed and approved the “Pilot Work Plan for Segmented Production of Biological Products” on October 18.